Circulating tumor DNA in early‐stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-4684|7|8|994-995

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.8, 2015-08, pp. : 994-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

By  

EMBO Molecular Medicine, Vol. 7, Iss. 8, 2015-08 ,pp. : 1034-1047

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinicopathological features and survival of early stage breast cancer in northwest China: A population‐based retrospective study of 1287 patients

By  

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 10-18

John Wiley & Sons Inc

Access to resources Recommend Favorite

ITIH5 induces a shift in TGF‐β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 167-181

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk Identification in the Early Design Stage Using Thermal Simulations—A Case Study

By Sajjadian Seyed Masoud  

Sustainability, Vol. 10, Iss. 1, 2018-01 ,pp. : 262-262

MDPI

Access to resources Recommend Favorite

Translational progress on tumor biomarkers

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 665-671

John Wiley & Sons Inc

Access to resources Recommend Favorite